In this study, we confirmed this process in 4T1 breast cancer cells, showing that PD-L1 expression on the cell membrane significantly decreased after short-term aPD-L1 treatment (24 h), but rebounded as the treatment prolonged (Supplementary Fig. 1A). This evidence concerns the gene CD274 and breast cancer.